-
Fantastic news: CUBIC PET/CT is up and running. We will start scanning our
#StatinTB trial participants early next year. Thanks to UCT and Gates Foundation for funding this important machine for research projects@UCT_news@UCT_Research@UCTIDM@gatesfoundation@BillGates@gmgh https://twitter.com/UCT_news/status/1194941476091973634 …pic.twitter.com/SAROAWRcOf
-
Small Change, Huge Impact: How an Existing Drug May Change TB Patients’ Lives. One year ago, the University of Namibia hosted the kickoff meeting for the new
@EDCTP project#StatinTB. Atorvastatin as adjunctive therapy in#tuberculosis to reduce post-TB chronic lung diseasepic.twitter.com/AOpCuuxtJm
-
Fantastic news
#StatinTB received approval from the Human Research Ethics Committee of the University of Cape Town@UCT_news#tuberculosis#HIVpic.twitter.com/zLAnDIBlii
-
University of Cape Town (UCT)
@UCT_news@UCT_Research@UCTIDM is the leading institution globally for#HIV research. Proud to be part of this inspiring team effort @UCT_GMGH#StatinTB@UZH_en@UZH_Science@Unispital_USZ . Global trends in HIV/AIDS research https://www.elsevier.com/connect/new-elsevier-report-charts-global-trends-in-hivaids-research …pic.twitter.com/Fl7BihyaLp
-
@GMGH_Africa at@UCT_news and@Unispital_USZ is currently recruiting a study coordinator for our#clinicaltrials in Cape Town metropole region#StatinTB aims to improve peoples lives at the end of#tuberculosis. Send applications by 11 February to join our fun team.pic.twitter.com/fKm7xeXR8Z
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.